STOCK TITAN

ADM Reports Third Quarter 2024 Results

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

ADM reported third quarter 2024 financial results with net earnings of $18 million and adjusted net earnings of $530 million. The company recorded a non-cash impairment charge of $461 million related to its Wilmar equity investment. Earnings per share were $0.04, with adjusted EPS of $1.09, both down versus prior year. Total segment operating profit was $1,037 million, down 28%. Year-to-date cash flows from operations were $2,468 million. The company completed its financial restatement with no impact on consolidated results for 2023 and first/second quarters of 2024. ADM maintains full-year 2024 adjusted EPS guidance of $4.50-$5.00.

ADM ha riportato i risultati finanziari del terzo trimestre 2024, con guadagni netti di 18 milioni di dollari e guadagni netti rettificati di 530 milioni di dollari. L'azienda ha registrato una rettifica non monetaria di 461 milioni di dollari relativa al suo investimento azionario in Wilmar. Gli utili per azione sono stati di 0,04 dollari, con un EPS rettificato di 1,09 dollari, entrambi in calo rispetto all'anno precedente. L'utile operativo totale del segmento è stato di 1.037 milioni di dollari, in diminuzione del 28%. I flussi di cassa dalle operazioni dall'inizio dell'anno ammontano a 2.468 milioni di dollari. L'azienda ha completato la sua rettifica finanziaria senza impatti sui risultati consolidati per il 2023 e i primi due trimestri del 2024. ADM mantiene la guida per l'EPS rettificato dell'intero anno 2024 di 4,50-5,00 dollari.

ADM informó los resultados financieros del tercer trimestre de 2024, con ganancias netas de 18 millones de dólares y ganancias netas ajustadas de 530 millones de dólares. La empresa registró un cargo por deterioro no monetario de 461 millones de dólares relacionado con su inversión en acciones de Wilmar. Las ganancias por acción fueron de 0,04 dólares, con un EPS ajustado de 1,09 dólares, ambos en descenso en comparación con el año anterior. El beneficio operativo total del segmento fue de 1.037 millones de dólares, una disminución del 28%. Los flujos de efectivo de las operaciones desde el inicio del año fueron de 2.468 millones de dólares. La empresa completó su ajuste financiero sin impacto en los resultados consolidados para 2023 y los primeros/segundos trimestres de 2024. ADM mantiene la guía de EPS ajustado para todo el año 2024 de 4,50-5,00 dólares.

ADM은 2024년 3분기 재무 결과를 보고하며, 순이익이 1,800만 달러, 조정된 순이익이 5억 3천만 달러에 달한다고 발표했습니다. 회사는 윌마르 주식 투자와 관련하여 4억 6,100만 달러의 비현금 손상차손을 기록했습니다. 주당 순이익은 0.04달러였고 조정된 EPS는 1.09달러로 둘 다 작년 대비 하락했습니다. 총 세그먼트 운영 이익은 10억 3천만 달러로 28% 감소했습니다. 올해 누적 운영 현금 흐름은 24억 6,800만 달러에 달합니다. 회사는 2023년 및 2024년 1/2분기에 대한 통합 결과에 영향을 주지 않는 재무 재정정을 완료했습니다. ADM은 2024년 전체 조정 EPS 목표를 4.50-5.00달러로 유지합니다.

ADM a annoncé les résultats financiers du troisième trimestre 2024, avec un bénéfice net de 18 millions de dollars et un bénéfice net ajusté de 530 millions de dollars. L'entreprise a enregistré une charge de dépréciation non monétaire de 461 millions de dollars liée à son investissement en actions chez Wilmar. Le bénéfice par action était de 0,04 dollar, avec un BPA ajusté de 1,09 dollar, tous deux en baisse par rapport à l'année précédente. Le bénéfice d'exploitation total du segment s'élevait à 1.037 millions de dollars, en baisse de 28%. Les flux de trésorerie d'exploitation depuis le début de l'année s'élevaient à 2.468 millions de dollars. L'entreprise a terminé sa régularisation financière sans impact sur les résultats consolidés pour 2023 et les premier/deuxième trimestres de 2024. ADM maintient ses prévisions de BPA ajusté pour l'année 2024 entre 4,50 et 5,00 dollars.

ADM hat die finanziellen Ergebnisse des dritten Quartals 2024 veröffentlicht, mit einem Nettogewinn von 18 Millionen Dollar und einem bereinigten Nettogewinn von 530 Millionen Dollar. Das Unternehmen verzeichnete einen nicht zahlungswirksamen Wertminderungsaufwand von 461 Millionen Dollar im Zusammenhang mit seiner Wilmar-Aktieninvestition. Der Gewinn pro Aktie betrug 0,04 Dollar, mit einem bereinigten EPS von 1,09 Dollar, beides im Rückgang im Vergleich zum Vorjahr. Der gesamte Segmentbetriebsgewinn betrug 1.037 Millionen Dollar, was einem Rückgang von 28% entspricht. Die operativen Cashflows seit Jahresbeginn beliefen sich auf 2.468 Millionen Dollar. Das Unternehmen hat seine Finanzberichterstattung ohne Auswirkungen auf die konsolidierten Ergebnisse für 2023 und das erste/zweite Quartal 2024 abgeschlossen. ADM hält die Prognose für das bereinigte EPS für das Gesamtjahr 2024 bei 4,50-5,00 Dollar.

Positive
  • Year-to-date cash flows from operating activities increased to $2,468 million from $1,891 million in prior year
  • Strong performance in Starches & Sweeteners with 13% profit growth
  • Animal Nutrition operating profit increased 58% to $19 million
Negative
  • $461 million non-cash impairment charge on Wilmar investment
  • Total segment operating profit declined 28% to $1,037 million
  • Ag Services & Oilseeds profit dropped 43% to $480 million
  • Nutrition segment profit decreased 19% to $105 million
  • Net earnings fell to $18 million from prior year

Insights

ADM's Q3 2024 results reveal significant challenges, with $18 million in net earnings and adjusted net earnings of $530 million. The most notable impact was a $461 million non-cash impairment charge related to Wilmar investment, severely affecting GAAP earnings.

Key metrics show concerning trends: Total segment operating profit declined 28% to $1.037 billion. Ag Services & Oilseeds segment saw the steepest decline of 43%, while Carbohydrate Solutions and Nutrition segments dropped 3% and 19% respectively.

The full-year guidance of $4.50 to $5.00 adjusted EPS indicates management expects continued headwinds from slower market demand and operational challenges. The completion of financial restatements provides some clarity, though the Wilmar investment situation requires ongoing monitoring.

The operational environment shows significant market pressures across all segments. In Ag Services, slower farmer selling and higher logistics costs are impacting margins. The crushing business faces challenges from higher canola seed prices in Europe, while biodiesel margins are compressed due to increased competition from used cooking oil imports.

Looking forward, Q4 projections suggest continued weakness in AS&O segment, with only partial offset from improved Ag Services conditions. The Nutrition segment's ongoing operational challenges, including the Decatur East downtime, signal persistent headwinds into 2024. These factors, combined with softer consumer demand, indicate a challenging near-term outlook for ADM's core business segments.

Files Restated Fiscal Year 2023 Form 10-K and Subsequent Forms 10-Q

As Expected, Restatement Had No Impact on Consolidated Financial Results for 2023 and First and Second Quarters of 2024

Company to Host Conference Call on December 3, 2024

CHICAGO--(BUSINESS WIRE)-- ADM (NYSE: ADM) today reported financial results for the quarter ended September 30, 2024 that are consistent with its previously announced preliminary results, and also filed its third quarter form 10-Q. The Company also filed its restated financial statements in its fiscal year 2023 Form 10-K and its forms 10-Q for the first and second quarters of 2024. The restatement did not impact the Company’s consolidated financial results for any of the periods covered by those reports, as noted below.

Third Quarter 2024 Highlights

  • Net earnings of $18 million, adjusted net earnings2 of $530 million
    • See below for impact of non-cash charge against GAAP earnings for the third quarter of $461 million related to our Wilmar equity investment
  • Earnings per share2 of $0.04, with adjusted earnings per share1,2 of $1.09, both down versus the prior year period
  • Trailing four-quarter average return on invested capital (ROIC) of 6.6%, trailing four-quarter average adjusted return on invested capital (ROIC)1 of 8.8%

Year-to-date cash flows from operating activities were $2,468 million, with cash flows from operations before working capital1,3 of $2,341 million, as compared to cash flows from operating activities of $1,891 million and cash flows from operations before working capital1,3 of $3,804 million for the corresponding prior-year year-to-date period.

“Accuracy and transparency are important to the Company and we are pleased to have now completed the restatement and be current with our financial filing. We continue to focus on implementing enhancements to internal controls to ensure integrity and accuracy of reporting,” said Chair of the Board and CEO Juan Luciano.

“Looking ahead, while we foresee softer market conditions into next year, we are taking actions to improve performance and drive value creation. We are redoubling our focus on productivity and operational excellence, while maintaining our disciplined approach to capital allocation.”

1 Non-GAAP financial measures; see pages 7-9 and 14-16 for explanations and reconciliations.

2 All references in this document to earnings per share (EPS) and adjusted earnings per share reflect EPS on a diluted basis.

3 Cash from operations before working capital is cash from operating activities of $2,468 million less the changes in working capital of $127 million in YTD 2024. Cash from operations before working capital is cash from operating activities of $1,891 million excluding the changes in working capital of ($1,913) million in YTD 2023

Third Quarter and Year-to-Date 2024 Results

3Q 2024 Results Overview

 

 

($ in millions except per share amounts)

 

 

 

Earnings Before Income Taxes

EPS1 (as reported)

GAAP

 

$108

$0.04

vs. 3Q 2023

 

(90)%

(97)%

 

 

 

 

 

 

Total Segment Operating Profit2

Adjusted EPS1,2

NON-GAAP

 

$1,037

$1.09

vs 3Q 2023

 

(28)%

(33)%

YTD 2024 Results Review

($ in millions except per share amounts)

 

 

 

Earnings Before Taxes

EPS1 (as reported)

GAAP

 

$1,588

$2.48

vs. YTD 2023

 

(55)%

(54)%

 

 

 

 

 

 

Total Segment Operating Profit2

Adjusted EPS2

NON-GAAP

 

$3,158

$3.61

vs YTD 2023

 

(32)%

(36)%

 

1 All references in this document to earnings per share (EPS) and adjusted earnings per share reflect EPS on a diluted basis.

2 Non-GAAP financial measures; see pages 7-9 and 14-16 for explanations and reconciliations.

Summary of Third Quarter and Year-to-Date 2024

For the third quarter ended September 30, 2024, earnings before income taxes were $108 million, down (90)% versus the prior year quarter. During the third quarter of 2024, the Company recorded a non-cash impairment charge against GAAP earnings of $461 million related to its equity investment in Wilmar. Earnings per share on a GAAP basis were $0.04, and adjusted earnings per share were $1.09, both down versus the prior year quarter. Total segment operating profit was $1,037 million, down (28)% versus the prior year quarter, and excluded specified items of $504 million, or approximately $1.03 per share, related to impairments.

Earnings before income taxes were $1,588 million year-to-date in 2024, down (55)% versus the prior year period. Total segment operating profit was $3,158 million year-to-date in 2024, down (32)%. Earnings per share on a GAAP basis were $2.48 and adjusted earnings per share were $3.61, down versus the prior year.

3Q 2024 Segment Overview

($ in millions, except where noted)

3Q 2024

3Q 20232

% Change

Total Segment Operating Profit1

$1,037

$1,446

(28)%

Segment Operating Profit:

 

 

 

Ag Services & Oilseeds

480

848

(43)%

Carbohydrate Solutions

452

468

(3)%

Nutrition

105

130

(19)%

 

 

 

 

YTD 2024 Segment Overview

($ in millions, except where noted)

YTD 2024

YTD 20232

% Change

Total Segment Operating Profit1

$3,158

$4,616

(32)%

Segment Operating Profit:

 

 

 

Ag Services & Oilseeds

1,803

3,113

(42)%

Carbohydrate Solutions

1,057

1,066

(1)%

Nutrition

298

437

(32)%

 

 

 

 

 

1 Non-GAAP financial measure; see pages 7-9 and 14-16 for explanation and reconciliation.

2 2023 Ag Services & Oilseeds, Carbohydrate Solutions, and Nutrition segment operating profits have been restated to reflect corrections with no change to total Segment Operating Profit. See Note 13, Segment Information of the Company’s consolidated financial statements included in the Quarterly Report on Form 10-Q for the quarter ended September 30, 2024.

Ag Services and Oilseeds Segment Summary

AS&O segment operating profit was $480 million during the third quarter of 2024, down (43)% compared to the prior year quarter.

The Ag Services subsegment operating profit was (53)% lower versus the prior year quarter, primarily due to lower results in South America Origination, as slower farmer selling and higher logistics costs related to industry take-or-pay contracts led to lower margins. The prior year quarter also included $48M of insurance proceeds related to Hurricane Ida.

The Crushing subsegment operating profit was (25)% lower versus the prior year quarter. Global soybean crush margins were higher, supported by strong margins in EMEA. However, higher canola seed prices due to less supply in Europe drove lower canola crush margins, leading to lower results. During the quarter, there were approximately zero mark-to-market timing impacts versus approximately $100 million of positive impacts from the same period a year ago, totaling approximately $100 million of negative net impacts versus the prior year. The current quarter also included $24 million of insurance proceeds for the partial settlement of the Decatur East and West insurance claims related to incidents in 2023.

The Refined Products & Other (RPO) subsegment operating profit was (63)% lower versus the prior year quarter, primarily driven by lower results in North America, as higher imports of used cooking oil and increased pre-treatment capacity drove significantly lower refining and global biodiesel margins. During the quarter, there were negative mark-to-market timing impacts in RPO of approximately $20 million versus approximately $100 million of positive timing impacts in the prior year, totaling approximately $120 million of negative net impacts year over year.

Equity earnings from the Company’s investment in Wilmar were $62 million during the quarter compared to the prior year quarter of $35 million.

Year-to-date in 2024, the AS&O segment delivered $1,803 million in segment operating profit, lower versus the elevated prior year. Ample supplies out of South America created more balanced supply and demand conditions, leading to a lower margin environment in the segment. Improved segment volumes and lower costs partially offset the impact from lower margins. Equity earnings from the Company’s Wilmar investment were 20% higher versus the comparable prior year period.

3Q 2024 AS&O Overview

($ in millions, except where noted)

3Q 2024

3Q 2023

% Change

Segment Operating Profit

$480

$848

(43)%

Ag Services

107

226

(53)%

Crushing

187

250

(25)%

Refined Products and Other

124

337

(63)%

Wilmar

62

35

77%

 

 

 

 

YTD 2024 AS&O Overview

($ in millions, except where noted)

YTD 2024

YTD 2023

% Change

Segment Operating Profit

$1,803

$3,113

(42)%

Ag Services

461

954

(52)%

Crushing

632

901

(30)%

Refined Products and Other

431

1,026

(58)%

Wilmar

279

232

20%

 

 

 

 

Carbohydrate Solutions Segment Summary

Carbohydrate Solutions segment operating profit was $452 million for the third quarter of 2024, down (3)% compared to the prior year period.

The Starches & Sweeteners subsegment increased 13%, versus the prior year period, primarily driven by strong starches and sweeteners volumes and margins, supported by high utilization rates across the network. The current quarter also included $47 million of insurance proceeds for the partial settlement of the Decatur West insurance claims related to an incident that occurred in 2023.

In the Vantage Corn Processing (VCP) subsegment, operating loss of $(3) million was lower compared to the prior year period, driven by higher inventories and production, leading to a lower margin environment.

Year-to-date in 2024, Carbohydrate Solutions segment operating profit of $1,057 million was (1)% lower than the prior year, as lower margins in the EMEA region and lower domestic ethanol margins were partially offset by improved volumes and lower costs.

3Q 2024 Carbohydrate Solutions Overview

($ in millions, except where noted)

3Q 2024

3Q 2023

% Change

Segment Operating Profit

$452

$468

(3)%

Starches and Sweeteners

455

403

13%

Vantage Corn Processors

(3)

65

(105)%

 

 

 

 

YTD 2024 Carbohydrate Solutions Overview

($ in millions, except where noted)

YTD 2024

YTD 2023

% Change

Segment Operating Profit

$1,057

$1,066

(1)%

Starches and Sweeteners

1,039

1,017

2%

Vantage Corn Processors

18

49

(63)%

 

 

 

 

Nutrition Segment Summary

Nutrition segment operating profit was $105 million for the third quarter of 2024, down (19)% compared to the prior year period.

Human Nutrition subsegment operating profit was $86 million, approximately (27)% lower versus the prior year period. These results include solid performance by recent Flavors M&A, lapping of non-recurring benefits in the prior year period, changes in inventory adjustments and certain other costs, including costs associated with the closure of a joint venture. The current quarter also included $25 million of insurance proceeds for the partial settlement of the Decatur East insurance claims related to an incident that occurred in 2023.

In the Animal Nutrition subsegment, operating profit of $19 million was 58% higher compared to prior year quarter, as cost optimization efforts and lower input costs supported higher margins.

Year-to-date in 2024, Nutrition segment operating profit of $298 million was (32)% lower than the prior year period, primarily driven by negative impacts related to unplanned downtime at Decatur East, lower texturants margins, and higher costs in Human Nutrition.

3Q 2024 Nutrition Overview

($ in millions, except where noted)

3Q 2024

3Q 2023

% Change

Segment Operating Profit

$105

$130

(19)%

Human Nutrition

86

118

(27)%

Animal Nutrition

19

12

58%

 

 

 

 

YTD 2024 Nutrition Overview

($ in millions, except where noted)

YTD 2024

YTD 2023

% Change

Segment Operating Profit

$298

$437

(32)%

Human Nutrition

265

441

(40)%

Animal Nutrition

33

(4)

NM

 

 

 

 

Other and Corporate Summary

For the third quarter, Other business operating loss was $17 million, down $63 million versus the prior year period, due to lower Captive insurance results from $112 million in claim settlements. Included in claim settlements were partial settlements of $96 million for the Decatur East and West insurance claims. ADM Investor Services results decreased on lower interest income.

Year-to-date in 2024, Other business operating gain was $200 million, down $29 million versus the prior year period, due to lower Captive insurance results from $112 million in claim settlements. Included in claim settlements were partial settlements of $96 million for the Decatur East and West insurance claims. ADM Investor Services results decreased on lower interest income.

In Corporate for the third quarter, unallocated corporate costs increased versus the prior year on $28 million in higher legal fees and $14 million in higher financing costs, partially offset by lower incentive compensation.

In Corporate for year-to-date 2024, unallocated corporate costs increased versus the prior year on higher global technology investments to support digital transformation efforts, $75 million in increased legal fees, and $33 million in increased financing costs, partially offset by lower incentive compensation. Other Corporate was unfavorable compared to the prior year period due to investment valuation losses partially offset by foreign currency gains.

Outlook3

The Company affirmed its previously provided EPS guidance for the full year. ADM expects adjusted earnings per share1,2 in the range of $4.50 to $5.00 for the full year 2024 based on trends in ADM’s performance to date, legislative and regulatory policy uncertainties, and ongoing headwinds from slower market demand and internal operational challenges.

Within the reportable segments, for the fourth quarter compared to the prior year period, the Company anticipates lower year-over-year segment operating profit in AS&O, as an improved environment in Ag Services is expected to be more than offset by lower margins in Crushing and Refined Products & Other. In Carbohydrate Solutions, solid demand and margins in North American Starches & Sweeteners and strong fundamentals in ethanol are expected to be offset by moderating wheat milling margins, leading to fourth quarter segment operating profit that is roughly in-line with the prior year period. In Nutrition, the Company anticipates the fourth quarter operating profit will be higher than the prior year period, but lower than the third quarter of 2024, due to softer consumer demand, lower texturants pricing, and ongoing operational challenges, including prolonged downtime at Decatur East.

Wilmar

GAAP earnings include a reduction in the carrying value of the Wilmar equity investment to reflect the Singapore Exchange trading price as of the balance sheet date. The reduction resulted from a determination that declines in the valuation amount for our investment are impaired on an “other than temporary” basis as of the end of the quarter. This has resulted in a non-cash charge against GAAP earnings for the third quarter of 2024 of $461 million. The Company is continuing to evaluate trends in the trading price of our Wilmar equity investment and the potential for future charges that could result.

1Non-GAAP financial measures; see pages 7-9 and 14-16 for explanations and reconciliations.

2 All references in this document to earnings per share (EPS) and adjusted earnings per share reflect EPS on a diluted basis.

3 Forecasted GAAP Earnings Reconciliation: ADM is not presenting forecasted GAAP earnings per diluted share or a quantitative reconciliation to forecasted adjusted earnings per share in reliance on the unreasonable efforts exemption provided under Item 10(e)(1)(i)(B) of Regulation S-K. ADM is unable to predict with reasonable certainty and without unreasonable effort the impact of any impairment and timing of restructuring-related and other charges, along with acquisition-related expenses and the outcome of certain regulatory, legal and tax matters. The financial impact of these items is uncertain and is dependent on various factors, including timing, and could be material to our Consolidated Statements of Earnings.

Restated Financial Statements

As previously disclosed, following ongoing dialogue with the staff of the United States Securities and Exchange Commission, the Company concluded that it would amend the Company’s fiscal year 2023 Form 10-K (the “FY2023 Form 10-K”) and Form 10-Q for the first and second quarters of 2024 (collectively, the “Q1 and Q2 2024 Form 10-Qs”). The Company has now filed the amended FY2023 Form 10-K and the amended Q1 and Q2 2024 Form 10-Qs, which contain the restated financial statements for each of the periods included in those filings, including fiscal years 2021, 2022 and 2023 in the FY2023 Form 10-K and each of the quarterly and year-to-date periods included in the Q1 and Q2 2024 Form 10-Qs (collectively, the “Restatements”). Because the transactions affected by the restatement occurred between the Company’s reporting segments, the restatement had no impact on ADM’s consolidated balance sheet, earnings, or cash flows for the periods presented in the restated filings.

Conference Call Information

ADM will host a webcast on December 3, 2024 at 8 a.m. Central Time to discuss financial results and outlook. To listen to the webcast, go to www.adm.com/webcast. A replay of the webcast will also be available for an extended period of time at www.adm.com/webcast.

About ADM

ADM unlocks the power of nature to enrich the quality of life. We’re an essential global agricultural supply chain manager and processor, providing food security by connecting local needs with global capabilities. We’re a premier human and animal nutrition provider, offering one of the industry’s broadest portfolios of ingredients and solutions from nature. We’re a trailblazer in health and well-being, with an industry-leading range of products for consumers looking for new ways to live healthier lives. We’re a cutting-edge innovator, guiding the way to a future of new consumer and industrial solutions. And we're a leader in sustainability, scaling across entire value chains to help decarbonize the multiple industries we serve. Around the globe, our innovation and expertise are meeting critical needs while nourishing quality of life and supporting a healthier planet. Learn more at www.adm.com.

Cautionary Note Regarding Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 that involve substantial risks and uncertainties. All statements, other than statements of historical fact included in this release, are forward-looking statements. You can identify forward-looking statements by the fact they do not relate strictly to historical or current facts. These statements may include words such as “anticipate,” “estimate,” “expect,” “project,” “plan,” “intend,” “believe,” “may,” “outlook,” “will,” “should,” “can have,” “likely,” and other words and terms of similar meaning in connection with any discussion of the timing or nature of future operating or financial performance or other events. All forward-looking statements are subject to significant risks, uncertainties and changes in circumstances that could cause actual results and outcomes to differ materially from the forward-looking statements. These forward-looking statements are not guarantees of future performance and involve risks, assumptions and uncertainties, including, without limitation, those described in the Company’s most recent Annual Report on Form 10-K and in other documents that the Company files or furnishes with the Securities and Exchange Commission. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual outcomes may vary materially from those indicated or anticipated by such forward-looking statements. Accordingly, you are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date they are made. Except to the extent required by law, ADM does not undertake, and expressly disclaims, any duty or obligation to update publicly any forward-looking statement after the date of this announcement, whether as a result of new information, future events, changes in assumptions or otherwise.

Non-GAAP Financial Measures

The Company uses certain “Non-GAAP” financial measures as defined by the Securities and Exchange Commission. These are measures of performance not defined by accounting principles generally accepted in the United States, and should be considered in addition to, not in lieu of, GAAP reported measures. Reconciliations of these non-GAAP financial measures to the most directly comparable GAAP financial measures are included in this press release.

Adjusted net earnings and Adjusted earnings per share (EPS). Adjusted net earnings reflects ADM’s reported net earnings after removal of the effect on net earnings of specified items as more fully described in the reconciliation tables below. Adjusted EPS reflects ADM’s fully diluted EPS after removal of the effect on EPS as reported of specified items as more fully described in the reconciliation tables below. Management believes that Adjusted net earnings and Adjusted EPS are useful measures of ADM’s performance because they provide investors additional information about ADM’s operations allowing better evaluation of underlying business performance and better period-to-period comparability. These non-GAAP financial measures are not intended to replace or be alternatives to net earnings and EPS as reported, the most directly comparable GAAP financial measures, or any other measures of operating results under GAAP. Earnings amounts described above have been divided by the company’s diluted shares outstanding for each respective period in order to arrive at an adjusted EPS amount for each specified item.

Total segment operating profit. Total segment operating profit is ADM’s consolidated earnings before income taxes adjusted for Other business, Corporate, and specified items as more fully described in the reconciliation tables below. Management believes that total segment operating profit is a useful measure of ADM’s performance because it provides investors information about ADM’s reportable segment performance excluding other business, corporate overhead costs as well as specified items. Total segment operating profit is not a measure of consolidated operating results under U.S. GAAP and should not be considered an alternative to earnings before income taxes, the most directly comparable GAAP financial measure, or any other measure of consolidated operating results under U.S. GAAP. The Company is revising its reconciliation and calculation of total segment operating profit. The revised reconciliation is presented in Note 13. Segment Information of the Company’s consolidated financial statements included in the Quarterly Report on Form 10-Q for the quarter ended September 30, 2024, which presents a subtotal for total segment operating profit that is equal to the sum of the segment operating profit reported for each of the Ag Services and Oilseeds, Carbohydrate Solutions and Nutrition segments. Amounts for Other business and specified items, which previously were reflected in the calculation of total segment operating profit, are now reflected as reconciling items, similar to Corporate, between total segment operating profit and earnings before income taxes

Adjusted Return on Invested Capital (ROIC). Adjusted ROIC is Adjusted ROIC earnings divided by adjusted invested capital. Adjusted ROIC earnings is ADM’s net earnings adjusted for the after-tax effects of interest expense on borrowings and specified items. Adjusted invested capital is the sum of ADM’s equity (excluding redeemable and non-redeemable noncontrolling interests) and interest-bearing liabilities (which totals invested capital), adjusted for specified items. Management believes Adjusted ROIC is a useful financial measure because it provides investors information about ADM’s returns excluding the impacts of specified items and increases period-to-period comparability of underlying business performance. Management uses Adjusted ROIC to measure ADM’s performance by comparing Adjusted ROIC to its weighted average cost of capital (WACC). Adjusted ROIC, Adjusted ROIC earnings and Adjusted invested capital are non-GAAP financial measures and are not intended to replace or be alternatives to GAAP financial measures.

Cash flow from operations before working capital is defined as cash flow from operating activities excluding the changes in operating assets and liabilities as presented in the Company’s consolidated statement of cash flows. Management believes that cash flow from operations before working capital is a useful measure of the Company’s cash generation. Cash flow from operations before working capital is a non-GAAP financial measure and is not intended to replace or be an alternative to cash from operating activities, the most directly comparable GAAP financial measure.

EBITDA is defined as earnings before interest, taxes, depreciation and amortization. Adjusted EBITDA is defined as earnings before interest on borrowings, taxes, depreciation, and amortization, adjusted for specified items. The Company calculates adjusted EBITDA by removing the impact of specified items and adding back the amounts of income tax expense, interest expense on borrowings, and depreciation and amortization to net earnings. Management believes that EBITDA and adjusted EBITDA are useful measures of the Company’s performance because they provide investors additional information about the Company’s operations allowing better evaluation of underlying business performance and better period-to-period comparability. EBITDA and adjusted EBITDA are non-GAAP financial measures and are not intended to replace or be an alternative to net earnings, the most directly comparable GAAP financial measure.

Financial Tables Follow

Source: Corporate Release

Source: ADM

Total Segment Operating Profit (a non-GAAP financial measure) and Corporate Results

(unaudited)

 

Quarter ended

 

 

Nine months ended

 

 

September 30

 

 

September 30

 

(In millions)

2024

2023

Change

 

2024

2023

Change

 

 

 

 

 

 

 

 

Earnings before income taxes

$

108

 

$

1,031

 

$

(923

)

 

$

1,588

 

$

3,560

 

$

(1,972

)

Other Business (earnings) loss

 

17

 

 

(46

)

 

63

 

 

 

(200

)

 

(229

)

 

29

 

Corporate

 

409

 

 

390

 

 

19

 

 

 

1,254

 

 

1,105

 

 

149

 

Specified items:

 

 

 

 

 

 

 

(Gain) loss on sales of assets

 

(1

)

 

2

 

 

(3

)

 

 

(1

)

 

(10

)

 

9

 

Impairment and restructuring charges

 

504

 

 

69

 

 

435

 

 

 

517

 

 

190

 

 

327

 

Total Segment Operating Profit

$

1,037

 

$

1,446

 

$

(409

)

 

$

3,158

 

$

4,616

 

$

(1,458

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Segment Operating Profit:

 

 

 

 

 

 

 

Ag Services and Oilseeds

$

480

 

$

848

 

$

(368

)

 

$

1,803

 

$

3,113

 

$

(1,310

)

Ag Services

 

107

 

 

226

 

 

(119

)

 

 

461

 

 

954

 

 

(493

)

Crushing

 

187

 

 

250

 

 

(63

)

 

 

632

 

 

901

 

 

(269

)

Refined Products and Other

 

124

 

 

337

 

 

(213

)

 

 

431

 

 

1,026

 

 

(595

)

Wilmar

 

62

 

 

35

 

 

27

 

 

 

279

 

 

232

 

 

47

 

 

 

 

 

 

 

 

 

Carbohydrate Solutions

$

452

 

$

468

 

$

(16

)

 

$

1,057

 

$

1,066

 

$

(9

)

Starches and Sweeteners

 

455

 

 

403

 

 

52

 

 

 

1,039

 

 

1,017

 

 

22

 

Vantage Corn Processors

 

(3

)

 

65

 

 

(68

)

 

 

18

 

 

49

 

 

(31

)

 

 

 

 

 

 

 

 

Nutrition

$

105

 

$

130

 

$

(25

)

 

$

298

 

$

437

 

$

(139

)

Human Nutrition

 

86

 

 

118

 

 

(32

)

 

 

265

 

 

441

 

 

(176

)

Animal Nutrition

 

19

 

 

12

 

 

7

 

 

 

33

 

 

(4

)

 

37

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Corporate Results

$

(409

)

$

(390

)

$

(19

)

 

$

(1,254

)

$

(1,105

)

$

(149

)

 

 

 

 

 

 

 

 

Interest expense - net

 

(113

)

 

(98

)

 

(15

)

 

 

(351

)

 

(326

)

 

(25

)

Unallocated corporate costs

 

(306

)

 

(298

)

 

(8

)

 

 

(903

)

 

(808

)

 

(95

)

Other

 

10

 

 

11

 

 

(1

)

 

 

16

 

 

34

 

 

(18

)

Specified items:

 

 

 

 

 

 

 

Gain (loss) on debt conversion option

 

 

 

 

 

 

 

 

 

 

6

 

 

(6

)

Expenses related to acquisitions

 

 

 

(3

)

 

3

 

 

 

(4

)

 

(6

)

 

2

 

Restructuring and contingency charges

 

 

 

(2

)

 

2

 

 

 

(12

)

 

(5

)

 

(7

)

 

Total segment operating profit is ADM’s consolidated earnings before income taxes adjusted for Other business, Corporate, and specified items as more fully described in the reconciliation tables below. Management believes that total segment operating profit are useful measures of ADM’s performance because it provides investors information about ADM’s business unit performance excluding other business, corporate overhead costs as well as specified items. Total segment operating profit is not a measure of consolidated operating results under U.S. GAAP and should not be considered an alternative to earnings before income taxes, the most directly comparable GAAP financial measure, or any other measure of consolidated operating results under U.S. GAAP.

Consolidated Statements of Earnings

(unaudited)

 

 

Quarter ended

 

Nine months ended

 

September 30

 

September 30

 

2024

 

2023

 

2024

 

2023

 

(in millions, except per share amounts)

 

 

 

 

 

 

 

 

Revenues

$

19,937

 

 

$

21,695

 

 

$

64,032

 

 

$

70,957

 

Cost of products sold (1)

 

18,572

 

 

 

19,885

 

 

 

59,612

 

 

 

65,184

 

Gross profit

 

1,365

 

 

 

1,810

 

 

 

4,420

 

 

 

5,773

 

Selling, general, and administrative expenses (2)

 

905

 

 

 

815

 

 

 

2,763

 

 

 

2,537

 

Asset impairment, exit, and restructuring costs(3)

 

507

 

 

 

79

 

 

 

532

 

 

 

146

 

Equity in (earnings) losses of unconsolidated affiliates

 

(134

)

 

 

(83

)

 

 

(498

)

 

 

(408

)

Interest and investment income

 

(137

)

 

 

(152

)

 

 

(400

)

 

 

(428

)

Interest expense (4)

 

174

 

 

 

155

 

 

 

527

 

 

 

482

 

Other (income) expense - net (5)

 

(58

)

 

 

(35

)

 

 

(92

)

 

 

(116

)

Earnings before income taxes

 

108

 

 

 

1,031

 

 

 

1,588

 

 

 

3,560

 

Income tax expense (benefit) (6)

 

90

 

 

 

207

 

 

 

370

 

 

 

636

 

Net earnings including noncontrolling interests

 

18

 

 

 

824

 

 

 

1,218

 

 

 

2,924

 

 

 

 

 

 

 

 

 

Less: Net earnings (losses) attributable to noncontrolling interests

 

 

 

 

3

 

 

 

(15

)

 

 

6

 

Net earnings attributable to ADM

$

18

 

 

$

821

 

 

$

1,233

 

 

$

2,918

 

 

 

 

 

 

 

 

 

Diluted earnings per common share

$

0.04

 

 

$

1.52

 

 

$

2.48

 

 

$

5.35

 

 

 

 

 

 

 

 

 

Average diluted shares outstanding

 

483

 

 

 

540

 

 

 

497

 

 

 

546

 

 

 

 

 

 

 

 

 

(1) Includes a net reversal of charges related to inventory writedowns of $5 million and a contingency loss provision of $62 million related to import duties in the prior YTD.

(2) Includes acquisition-related expenses of $3 million and $6 million in the prior quarter and YTD, respectively, and a contingency loss adjustment of $8 million in the prior quarter and YTD.

(3) Includes charges related to the impairment of the Company's investment in Wilmar, impairment of discontinued animal nutrition trademarks and restructuring costs

(4) Includes (gains) losses related to the mark-to-market adjustment of the conversion option of the exchangeable bond issued in August 2020 of $6 million in the prior YTD.

(5) Includes net (gains) losses related to the sale of certain assets of $(1) million in the current quarter and YTD. Includes net (gains) losses related to the sale of certain assets of $2 million and $(10) million in the prior quarter and YTD, respectively.

(6) Includes the tax expense (benefit) impact of above specified items and tax discrete items totaling $9 million and $23 million in the current quarter and YTD, respectively, and $(17) million and $(38) million in the prior year quarter and YTD, respectively.

Summary of Financial Condition

(unaudited)

 

 

 

September 30,
2024

 

September 30,
2023

 

 

(in millions)

Net Investment In

 

 

 

 

Cash and cash equivalents

 

$

784

 

$

1,498

Operating working capital

 

 

9,297

 

 

11,036

Property, plant, and equipment

 

 

10,828

 

 

10,218

Investments in affiliates

 

 

5,142

 

 

5,469

Goodwill and other intangibles

 

 

6,999

 

 

6,392

Other non-current assets

 

 

2,604

 

 

2,492

 

 

$

35,654

 

$

37,105

Financed By

 

 

 

 

Short-term debt

 

$

1,733

 

$

116

Long-term debt, including current maturities

 

 

8,303

 

 

8,225

Deferred liabilities

 

 

3,351

 

 

3,183

Temporary equity

 

 

283

 

 

316

Shareholders’ equity

 

 

21,984

 

 

25,265

 

 

$

35,654

 

$

37,105

Summary of Cash Flows

(unaudited)

 

 

 

Nine months ended

 

 

September 30

 

 

2024

 

2023

 

 

(in millions)

Operating Activities

 

 

 

 

Net earnings

 

$

1,218

 

 

$

2,924

 

Depreciation and amortization

 

 

854

 

 

 

782

 

Asset impairment charges

 

 

517

 

 

 

120

 

(Gains) losses on sales/revaluation of assets

 

 

9

 

 

 

(33

)

Other - net

 

 

(257

)

 

 

11

 

Other changes in operating assets and liabilities

 

 

127

 

 

 

(1,913

)

Net Cash Provided by Operating Activities

 

 

2,468

 

 

 

1,891

 

 

 

 

 

 

Investing Activities

 

 

 

 

Purchases of property, plant and equipment

 

 

(1,071

)

 

 

(1,055

)

Net assets of businesses acquired

 

 

(936

)

 

 

(11

)

Proceeds from sale of business/assets

 

 

31

 

 

 

21

 

Investments in affiliates

 

 

(44

)

 

 

(8

)

Other investing activities

 

 

18

 

 

 

(8

)

Net Cash (Used) by Investing Activities

 

 

(2,002

)

 

 

(1,061

)

 

 

 

 

 

Financing Activities

 

 

 

 

Long-term debt borrowings

 

 

 

 

 

500

 

Long-term debt payments

 

 

 

 

 

(963

)

Net borrowings (payments) under lines of credit

 

 

1,627

 

 

 

(379

)

Share repurchases

 

 

(2,327

)

 

 

(1,118

)

Cash dividends

 

 

(744

)

 

 

(738

)

Other

 

 

(21

)

 

 

(102

)

Net Cash (Used) by Financing Activities

 

 

(1,465

)

 

 

(2,800

)

Effect of exchange rate on cash, cash equivalents, restricted cash, and restricted cash equivalents

 

 

6

 

 

 

(22

)

Increase (decrease) in cash, cash equivalents, restricted cash, and restricted cash equivalents

 

 

(993

)

 

 

(1,992

)

Cash, cash equivalents, restricted cash, and restricted cash equivalents - beginning of period

 

 

5,390

 

 

 

7,033

 

Cash, cash equivalents, restricted cash, and restricted cash equivalents - end of period

 

$

4,397

 

 

$

5,041

 

Segment Operating Analysis

(unaudited)

 

 

Quarter ended

 

Nine months ended

 

September 30

 

September 30

 

2024

 

2023

 

2024

 

2023

 

(in ‘000s metric tons)

Processed volumes (by commodity)

 

 

 

 

 

 

 

Oilseeds

 

8,410

 

 

8,648

 

 

26,669

 

 

26,058

Corn

 

4,943

 

 

4,507

 

 

13,833

 

 

13,349

Total processed volumes

 

13,353

 

 

13,155

 

 

40,502

 

 

39,407

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Quarter ended

 

Nine months ended

 

September 30

 

September 30

 

2024

 

2023

 

2024

 

2023

 

(in millions)

Revenues

 

 

 

 

 

 

 

Ag Services and Oilseeds

$

15,089

 

$

16,479

 

$

49,642

 

$

54,902

Carbohydrate Solutions

 

2,908

 

 

3,325

 

 

8,484

 

 

10,243

Nutrition

 

1,831

 

 

1,784

 

 

5,575

 

 

5,490

Other Business

 

109

 

 

107

 

 

331

 

 

322

Total revenues

$

19,937

 

$

21,695

 

$

64,032

 

$

70,957

Adjusted Net Earnings and Adjusted EPS

Non-GAAP financial measures

(unaudited)

 

 

Quarter ended September 30

 

Nine months ended September 30

 

2024

2023

 

2024

2023

 

In millions

Per share

In millions

Per share

 

In millions

Per share

In millions

Per share

Net earnings and fully diluted EPS

$

18

 

$

0.04

$

821

$

1.52

 

$

1,233

 

$

2.48

$

2,918

 

$

5.35

 

Adjustments:

 

 

 

 

 

 

 

 

 

Loss (gain) on sales of assets and businesses (a)

 

(1

)

 

 

2

 

 

 

(1

)

 

 

(7

)

 

(0.02

)

Impairment, restructuring charges and contingency provisions (b)

 

500

 

 

1.03

 

54

 

0.10

 

 

523

 

 

1.06

 

152

 

 

0.28

 

Expenses related to acquisitions (c)

 

 

 

 

3

 

0.01

 

 

3

 

 

0.01

 

5

 

 

0.01

 

Loss (gain) on debt conversion option (d)

 

 

 

 

 

 

 

 

 

 

(6

)

 

(0.01

)

Certain discrete tax adjustments (e)

 

13

 

 

0.02

 

 

 

 

30

 

 

0.06

 

3

 

 

0.01

 

Sub-total adjustments

 

512

 

 

1.05

 

59

 

0.11

 

 

555

 

 

1.13

 

147

 

 

0.27

 

Adjusted net earnings and adjusted EPS

$

530

 

$

1.09

$

880

$

1.63

 

$

1,788

 

$

3.61

$

3,065

 

$

5.62

 

Current quarter and YTD gain of $1 million and $(1) million pretax ($(1) million and $(1) million after tax), respectively, was related to the sale of certain assets, tax effected using the applicable tax rate. Prior quarter and YTD (gain) loss of $2 million and $(10) million pretax ($2 million and $(7) million after tax), respectively, was related to the sale of certain assets, tax effected using the applicable tax rate.

(a)

Current quarter and YTD gain of $1 million and $(1) million pretax ($(1) million and $(1) million after tax), respectively, was related to the sale of certain assets, tax effected using the applicable tax rate. Prior quarter and YTD (gain) loss of $2 million and $(10) million pretax ($2 million and $(7) million after tax), respectively, was related to the sale of certain assets, tax effected using the applicable tax rate.

(b)

Current quarter and YTD charges of $504 million and $529 million pretax ($500 million and $523 million after tax), respectively were related to the impairment of the Company's investment in Wilmar, impairment of discontinued animal nutrition trademarks, and restructuring, tax effected using the applicable tax rates. Prior quarter and YTD charges of $79 million and $141 million pretax ($60 million and $111 million after tax), respectively, were related to the impairment of certain assets and restructuring. Also included in the prior quarter and YTD is a contingency loss reversal of $8 million pretax ($6 million after tax) and a contingency provision related to import duties of $62 million pretax ($47 million after tax) in the prior YTD, tax effected using the applicable tax rates.

(c)

Current YTD expenses of $4 million ($3 million after tax) were related to certain acquisitions, tax effected using the Company’s U.S. income tax rate. Prior quarter and YTD expenses of $3 million and $6 million ($3 million and $5 million after tax), respectively, were related to certain acquisitions, tax effected using the Company’s U.S. income tax rate.

(d)

Prior YTD gain on debt conversion option of $6 million pretax ($6 million after tax).

(e)

Tax adjustments due to certain discrete items totaling $13 million and $30 million in the current quarter and YTD, respectively. Tax adjustments due to certain discrete items totaling $3 million in the prior YTD, respectively.

 

Adjusted net earnings reflects ADM’s reported net earnings after removal of the effect on net earnings of specified items as more fully described above. Adjusted EPS reflects ADM’s fully diluted EPS after removal of the effect on EPS as reported of specified items as more fully described above. Management believes that Adjusted net earnings and Adjusted EPS are useful measures of ADM’s performance because they provide investors additional information about ADM’s operations allowing better evaluation of underlying business performance and better period-to-period comparability. These non-GAAP financial measures are not intended to replace or be alternatives to net earnings and EPS as reported, the most directly comparable GAAP financial measures, or any other measures of operating results under GAAP. Earnings amounts described above have been divided by the company’s diluted shares outstanding for each respective period in order to arrive at an adjusted EPS amount for each specified item.

Adjusted Return on Invested Capital

A non-GAAP financial measure

(unaudited)

 

ROIC Earnings (in millions)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Four Quarters

 

Quarter Ended

 

Ended

 

Dec. 31, 2023

 

Mar. 31, 2024

 

Jun. 30, 2024

 

Sep. 30, 2024

 

Sep. 30, 2024

 

 

 

 

 

 

 

 

 

 

Net earnings attributable to ADM

$

565

 

 

$

729

 

 

$

486

 

 

$

18

 

 

$

1,798

 

Adjustments:

 

 

 

 

 

 

 

 

 

Interest expense

 

109

 

 

 

115

 

 

 

135

 

 

 

124

 

 

 

483

 

Tax on interest

 

(26

)

 

 

(27

)

 

 

(32

)

 

 

(30

)

 

 

(115

)

Total ROIC Earnings

$

648

 

 

$

817

 

 

$

589

 

 

$

112

 

 

$

2,166

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total ROIC Earnings

$

648

 

 

$

817

 

 

$

589

 

 

$

112

 

 

$

2,166

 

Other Adjustments

 

155

 

 

 

21

 

 

 

22

 

 

 

512

 

 

 

710

 

Total Adjusted ROIC Earnings

$

803

 

 

$

838

 

 

$

611

 

 

$

624

 

 

$

2,876

 

 

 

 

 

 

 

 

 

 

 

Invested Capital (in millions)

 

 

 

 

 

 

 

 

 

 

Quarter Ended

 

Trailing Four

 

Dec. 31, 2023

 

Mar. 31, 2024

 

Jun. 30, 2024

 

Sep. 30, 2024

 

Quarter Average

 

 

 

 

 

 

 

 

 

 

Equity (1)

$

24,132

 

$

23,219

 

$

22,148

 

$

21,974

 

$

22,868

 

+ Interest-bearing liabilities (2)

 

8,370

 

 

9,995

 

 

10,576

 

 

10,051

 

 

9,748

 

Total Invested Capital

$

32,502

 

$

33,214

 

$

32,724

 

$

32,025

 

$

32,616

 

 

 

 

 

 

 

 

 

 

 

Total Invested Capital

$

32,502

 

$

33,214

 

$

32,724

 

$

32,025

 

$

32,616

 

Other Adjustments

 

155

 

 

21

 

 

22

 

 

512

 

 

178

 

Total Adjusted Invested Capital

$

32,657

 

$

33,235

 

$

32,746

 

$

32,537

 

$

32,794

 

 

 

 

 

 

 

 

 

 

 

Return on Invested Capital

 

 

 

 

 

 

 

 

6.6

%

Adjusted Return on Invested Capital

 

 

 

 

 

 

 

 

8.8

%

 

(1) Excludes noncontrolling interests

(2) Includes short-term debt, current maturities of long-term debt, finance lease obligations, and long-term debt

 

ROIC is ROIC earnings divided by invested capital. ROIC earnings is ADM’s net earnings adjusted for the after-tax effects of interest expense on borrowings. Invested capital is the sum of ADM’s equity (excluding noncontrolling interests) and interest-bearing liabilities.

 

Adjusted ROIC is Adjusted ROIC earnings divided by adjusted invested capital. Adjusted ROIC earnings is ADM’s net earnings adjusted for the after-tax effects of interest expense on borrowings, and specified items. Adjusted invested capital is the sum of ADM’s equity (excluding noncontrolling interests) and interest-bearing liabilities adjusted for the after-tax effect of specified items. Adjusted ROIC on a trailing four quarter average basis is equal to the average trailing four quarters of adjusted ROIC earnings divided by the average trailing four quarters of adjusted invested capital. Management believes Adjusted ROIC is a useful financial measure because it provides investors information about ADM’s returns excluding the impacts of specified items and increases period-to-period comparability of underlying business performance. Management uses Adjusted ROIC to measure ADM’s performance by comparing Adjusted ROIC to its weighted average cost of capital (WACC). Adjusted ROIC, Adjusted ROIC earnings and Adjusted invested capital are non-GAAP financial measures and are not intended to replace or be alternatives to GAAP financial measures.

Adjusted Earnings Before Interest, Taxes, and Depreciation and Amortization (EBITDA)

A non-GAAP financial measure

(unaudited)

 

The tables below provide a reconciliation of net earnings to adjusted EBITDA for the trailing four quarters ended September 30, 2024.

 

 

 

 

 

 

 

 

 

Four Quarters

 

Quarter Ended

 

Ended

 

Dec. 31, 2023

 

Mar. 31, 2024

 

Jun. 30, 2024

 

Sep. 30, 2024

 

Sep. 30, 2024

 

 

 

 

 

(in millions)

 

 

 

 

Net earnings

$

565

 

 

$

729

 

 

$

486

 

 

$

18

 

 

$

1,798

 

Net earnings (losses) attributable to noncontrolling interests

 

(23

)

 

 

(10

)

 

 

(5

)

 

 

 

 

 

(38

)

Income tax expense

 

192

 

 

 

166

 

 

 

115

 

 

 

90

 

 

 

563

 

Interest expense

 

109

 

 

 

115

 

 

 

135

 

 

 

124

 

 

 

483

 

Depreciation and amortization

 

277

 

 

 

280

 

 

 

286

 

 

 

288

 

 

 

1,131

 

EBITDA

 

1,120

 

 

 

1,280

 

 

 

1,017

 

 

 

520

 

 

 

3,937

 

(Gain) loss on sales of assets and businesses

 

(7

)

 

 

 

 

 

 

 

 

(1

)

 

 

(8

)

Impairment and restructuring charges and contingency provisions

 

172

 

 

 

18

 

 

 

7

 

 

 

504

 

 

 

701

 

Railroad maintenance expense

 

39

 

 

 

 

 

 

4

 

 

 

28

 

 

 

71

 

Expenses related to acquisitions

 

1

 

 

 

 

 

 

4

 

 

 

 

 

 

5

 

Adjusted EBITDA

$

1,325

 

 

$

1,298

 

 

$

1,032

 

 

$

1,051

 

 

$

4,706

 

 

 

 

 

 

 

 

 

 

 

EBITDA is defined as earnings before interest, taxes, depreciation and amortization. Adjusted EBITDA is defined as earnings before interest on borrowings, taxes, depreciation, and amortization, adjusted for specified items. The Company calculates adjusted EBITDA by removing the impact of specified items and adding back the amounts of income tax expense, interest expense on borrowings, and depreciation and amortization to net earnings. Management believes that EBITDA and adjusted EBITDA are useful measures of the Company’s performance because they provide investors additional information about the Company’s operations allowing better evaluation of underlying business performance and better period-to-period comparability. EBITDA and adjusted EBITDA are non-GAAP financial measure and are not intended to replace or be an alternative to net earnings, the most directly comparable GAAP financial measure.

 

Media Contact

Brett Lutz

media@adm.com

312-634-8484

Investor Relations

Megan Britt

Megan.Britt@adm.com

872-257-8378

Source: ADM

FAQ

What was ADM's earnings per share (EPS) in Q3 2024?

ADM reported earnings per share of $0.04 and adjusted earnings per share of $1.09 for Q3 2024, both down compared to the prior year period.

How much was ADM's impairment charge related to Wilmar investment in Q3 2024?

ADM recorded a non-cash impairment charge of $461 million related to its Wilmar equity investment in Q3 2024.

What is ADM's full-year 2024 earnings guidance?

ADM expects adjusted earnings per share in the range of $4.50 to $5.00 for the full year 2024.

How did ADM's segment operating profit perform in Q3 2024?

ADM's total segment operating profit was $1,037 million in Q3 2024, down 28% compared to the prior year quarter.

Archer Daniels Midland Company

NYSE:ADM

ADM Rankings

ADM Latest News

ADM Stock Data

25.41B
494.44M
0.59%
80.67%
1.51%
Farm Products
Fats & Oils
Link
United States of America
CHICAGO